| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Neladenoson dalanate manufacturers
|
| | Neladenoson dalanate Basic information |
| Product Name: | Neladenoson dalanate | | Synonyms: | Neladenoson dalanate;BAY 10-67197;L-Alanine, L-alanyl-, 2-[4-[2-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-3,5-dicyano-6-(1-pyrrolidinyl)-4-pyridinyl]phenoxy]ethyl ester;BAY-1067197|||BAY-1067197|||Neladenoson bialanate;Neladenoson bialanate hydrochloride;Neladenoson bialanate | | CAS: | 1239309-58-0 | | MF: | C35H34ClN7O4S2 | | MW: | 716.27 | | EINECS: | | | Product Categories: | | | Mol File: | 1239309-58-0.mol |  |
| | Neladenoson dalanate Chemical Properties |
| density | 1.42±0.1 g/cm3(Predicted) | | pka | 13.69±0.46(Predicted) |
| | Neladenoson dalanate Usage And Synthesis |
| Uses | Neladenoson dalanate (Neladenoson bialanate; BAY-1067197) is a orally active agonist precursor of partial Adenosine A1 Receptor. Neladenoson dalanate has a good pharmacokinetic and safety profile, can be used for the chronic heart diseases[1]. | | IC 50 | A1R | | References | [1] Meibom D, et al. Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial AdenosineA1 Receptor Agonist for the Chronic Treatment of Heart Diseases. ChemMedChem. 2017 May 22;12(10):728-737. DOI:10.1002/cmdc.201700151 |
| | Neladenoson dalanate Preparation Products And Raw materials |
|